Kniss Jennifer M, Kibaba Georget, Baguma Emmanuel, Bhattarai Chhetri Sujata, Hendren Cate, Ntaro Moses, Mulogo Edgar, Karabyo Samson, Boyce Ross M
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
PHEALED, Bugoye, Uganda.
PLOS Glob Public Health. 2024 Oct 7;4(10):e0003794. doi: 10.1371/journal.pgph.0003794. eCollection 2024.
Pediatric severe malaria is a significant contributor of morbidity and mortality in Uganda. Most information is derived from tertiary referral centers and urban centers. Little is known about routine care or post-discharge outcomes in rural areas. We conducted a longitudinal cohort study of pediatric severe malaria at St. Paul's Level IV Health Center (SPHC) in Kasese, Uganda. We collected demographic, clinical, and laboratory results, and conducted follow-up 14 days post-discharge to assess patient outcomes in the immediate post-discharge period. The initial cohort included 187 children aged 0 to 17 years enrolled between July 9th, 2023 and January 9th, 2024. Almost all (94.7%) participants had a parasitological confirmed malaria diagnosis by rapid diagnostic tests or blood smear. While at SPHC, 95.7% of patients received 3+ doses of intravenous Artesunate, and 92.0% also received oral antimalarials. 62.0% had at least one symptom of severe malaria, with altered consciousness (40.6%) and convulsions (29.9%) the most frequently reported. 26.1% had evidence of severe malarial anemia (Hb <5 g/dl), of whom 93.5% received a blood transfusion. Most (82.2%) patients received care that we assessed as consistent with key elements of WHO management guidelines. We were able to contact 183 of the 187 patient caregivers post-discharge. Caregivers reported that 25.6% of patients were experiencing symptoms related to their hospitalization, with fever (18.5%) and nausea/ not feeding well (10.3%) reported most frequently. Children who experienced altered consciousness during their acute illness had 1.69 times the adjusted risk of reporting symptoms 14-days post-discharge compared to those who did not have altered consciousness (aRR: 1.69, 95% CI: 1.01-2.82). Six deaths were recorded, including three at SPHC and three post-transfer or discharge. Findings suggest that at private health facilities in rural areas, treatment appears to be consistent with guidelines. Future research should investigate high morbidity in the immediate post-discharge period.
小儿重症疟疾是乌干达发病和死亡的重要原因。大多数信息来自三级转诊中心和城市中心。对于农村地区的常规护理或出院后结局知之甚少。我们在乌干达卡塞塞的圣保罗四级健康中心(SPHC)对小儿重症疟疾进行了一项纵向队列研究。我们收集了人口统计学、临床和实验室结果,并在出院后14天进行随访,以评估出院后即刻的患者结局。初始队列包括2023年7月9日至2024年1月9日期间登记的187名0至17岁儿童。几乎所有(94.7%)参与者通过快速诊断检测或血涂片获得了寄生虫学确诊的疟疾诊断。在SPHC期间,95.7%的患者接受了3剂及以上静脉注射青蒿琥酯,92.0%的患者还接受了口服抗疟药。62.0%的患者至少有一项重症疟疾症状,意识改变(40.6%)和惊厥(29.9%)是最常报告的症状。26.1%的患者有重症疟疾贫血的证据(血红蛋白<5 g/dl),其中93.5%接受了输血。大多数(82.2%)患者接受的护理我们评估为符合世界卫生组织管理指南的关键要素。出院后,我们能够联系到187名患者护理人员中的183名。护理人员报告说,25.6%的患者仍有与住院相关的症状,最常报告的是发热(18.5%)和恶心/食欲不振(10.3%)。与未出现意识改变的儿童相比,急性疾病期间出现意识改变的儿童在出院后14天报告症状的调整风险高1.69倍(调整后风险比:1.69,95%置信区间:1.01-2.82)。记录了6例死亡,包括在SPHC的3例以及转院或出院后的3例。研究结果表明,在农村地区的私立卫生设施中,治疗似乎符合指南。未来的研究应调查出院后即刻的高发病率情况。